Navigation Links
ACR, SBI support updated ACOG recommendations that women begin annual mammograms at age 40
Date:7/20/2011

The American College of Radiology (ACR) and Society of Breast Imaging applaud and support updated American College of Obstetricians and Gynecologists' (ACOG) recommendations that women begin getting annual mammograms at age 40. The updated ACOG recommendations now correspond with those of the American Cancer Society, ACR, Society of Breast Imaging (SBI), American Society of Breast Disease (ASBD) and many other major medical associations with demonstrated expertise in breast cancer care.

Three decades of research shows that mammography saves lives. Recently, Tabar et al, an update to a landmark study that involved 130,000 women followed over 29 years, re-confirmed that regular mammography screening reduced the breast cancer death rate by 30 percent. This follows the report of the largest breast cancer screening trial ever performed (Hellquist et al), involving a million women over 16 years, which proved that mammography screening reduced breast cancer deaths in women 40-49 by 29 percent. Both fit with National Cancer Institute data that shows that since mammography screening became widespread in 1990, the U.S. breast cancer death rate, previously unchanged for 50 years, has dropped 37 percent.

The updated ACOG recommendations, now in-step with those of breast cancer experts, differ from the guidelines of the United States Preventive Services Task Force (USPSTF).

ACOG, like ACR, SBI, and others, placed greater importance on saving lives while the USPSTF was primarily concerned with reducing false positive studies, most of which are resolved by a few additional mammographic views or ultrasound. The USPSTF relied largely on computer modeling to argue that, in women 40-49, only those with a family history of breast cancer or other high-risk factors should be screened and that women 50-74 be screened biennially. However, there is no scientific data to support the age of 50 as a biological threshold for screening. It has been artificially marked by inappropriate grouping of data.

Moreover, 75 percent of women who develop breast cancer are not considered at high-risk for the disease. Screening only high risk women would miss three-quarters of breast cancers. The USPSTF conceded that biennial screening of those 50-74 would miss up to a third of cancers present. A report by Hendrick and Helvie, showed that if USPSTF breast cancer screening guidelines were followed, as many as 100,000 women, now ages 30-39, and preparing to enter screening age, would ultimately die unnecessarily from breast cancer.

Mammography is not perfect. It does not identify all breast cancers. However, at present there is nothing to replace mammography as a primary screening tool. By not getting annual mammograms, women increase their risk of dying from breast cancer. In addition, mammography can find cancers at an earlier stage when treatment options are greater.

Women ages 40 and older are strongly encouraged to seek annual mammograms. Those with a family history of breast cancer or other factors that place them at elevated risk for the disease should speak with their doctor about being screened even earlier.


'/>"/>

Contact: Shawn Farley
PR@acr.org
703-648-8936
American College of Radiology
Source:Eurekalert

Related medicine news :

1. International AIDS Society to launch Virtual Media Centre in July to support opioid substitution therapy in Eastern Europe and Central Asia
2. NIH supports new research strategy for finding a cure for HIV
3. Covidien supports NOSCAR US multicenter human trial
4. Emergency departments need to do more to support older adults with cognitive impairment
5. Avastin Rejection Supported by Cancer Experts
6. PACS improves radiologists use of clinical decision support systems
7. Nature Publishing Group supports ASCB Childcare Awards for scientist-parents at annual meeting
8. Text message support for smokers doubles quit rates
9. To fix diabetic nerve damage, blood vessels and support cells may be the real targets of treatment
10. New application for iPhone may support monitoring and research on Parkinsons disease
11. Support Is Key to Coming Out Process for Gay People: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 2016 , ... The Dan Carlisle Agency, an Alabama-owned firm ... announcing the launch of a charity drive to raise support and awareness for ... children in Birmingham has grown steadily since the 1980’s, and the Pathways organization ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Compretta Insurance Agency, a family owned ... and around the Hancock County area, is announcing the launch of a charity effort ... The Hancock County Food Pantry has worked for more than 30 years to meet ...
(Date:12/7/2016)... KING OF PRUSSIA, PA (PRWEB) , ... December 07, 2016 , ... ... of clinical trials with the announcement that it is one of the early adopters ... EU-U.S. Privacy Shield Framework is designed to provide companies on both sides of the ...
(Date:12/7/2016)... ... December 07, 2016 , ... Kenall Manufacturing, a leader in sealed healthcare ... The MPCNGX is a multi-function, sealed, LED luminaire that meets the needs of everyone ... when it’s needed. , A 2’ x 4’ model features four modes: ...
(Date:12/7/2016)... ... December 07, 2016 , ... Wavelink, an industry ... Control through a new partnership with Splashtop Inc. This remote control for Android ... to help businesses maximize their uptime and productivity. , Wavelink offers powerful enterprise ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... ANGELES , Dec. 8, 2016  Hanson ... manufacturing of dissolution testing and diffusion testing instruments ... been acquired by Teledyne Instruments, Inc. ("Teledyne"). The ... long-proven line of precision testing instruments, as well ... accelerating development of new products and services. ...
(Date:12/8/2016)... CANTEL MEDICAL CORP. (NYSE: CMD ) ... per diluted share, on a 22.1% increase in sales to ... 2016. This compares with net income of $14,254,000, or $0.34 ... quarter ended October 31, 2015. Non-GAAP net ... 2016 to $21,323,000, or $0.51 per diluted share, compared with ...
(Date:12/8/2016)... and SAN DIEGO , Dec. 8, 2016 ... solutions with cutting edge next-generation sequencing and bioinformatics expertise; AITbiotech ... and the Genome Institute of Singapore ... new joint venture between Novogene and AITbiotech – will establish ... Singapore .   The new centre ...
Breaking Medicine Technology: